Celularity Inc.
CELU · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $54 | $23 | $18 | $21 |
| % Growth | 138.1% | 26.7% | -15.7% | – |
| Cost of Goods Sold | $15 | $16 | $20 | $10 |
| Gross Profit | $39 | $7 | -$2 | $12 |
| % Margin | 72.4% | 29.7% | -9.4% | 54.8% |
| R&D Expenses | $17 | $30 | $78 | $88 |
| G&A Expenses | $59 | $51 | $66 | $0 |
| SG&A Expenses | $59 | $51 | $66 | $71 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2 | $118 | -$120 | -$39 |
| Operating Expenses | $78 | $199 | $24 | $121 |
| Operating Income | -$38 | -$192 | -$26 | -$109 |
| % Margin | -70.7% | -844.4% | -142.4% | -511.2% |
| Other Income/Exp. Net | -$20 | -$4 | $40 | $9 |
| Pre-Tax Income | -$58 | -$196 | $14 | -$100 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$58 | -$196 | $14 | -$100 |
| % Margin | -106.8% | -862% | 79% | -469.3% |
| EPS | -2.645 | -11.02 | 1.014 | -14.93 |
| % Growth | 76% | -1,186.3% | 106.8% | – |
| EPS Diluted | -2.645 | -11.02 | 0.947 | -14.93 |
| Weighted Avg Shares Out | 22 | 18 | 14 | 7 |
| Weighted Avg Shares Out Dil | 22 | 18 | 15 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $6 | $3 | $0 | $3 |
| Depreciation & Amortization | $8 | $9 | $9 | $9 |
| EBITDA | -$44 | -$184 | -$139 | -$88 |
| % Margin | -80.6% | -807.8% | -772.4% | -413% |